Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Protalix Biotherapeutics (NY: PLX ) 1.090 -0.030 (-2.68%) Official Closing Price Updated: 8:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 251,954 Open 1.140 Bid (Size) 1.050 (10) Ask (Size) 1.160 (375) Prev. Close 1.120 Today's Range 1.080 - 1.140 52wk Range 1.020 - 2.090 Shares Outstanding 73,316,084 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Friday's Pre-Market Session May 17, 2024 Via Benzinga PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024 May 10, 2024 PLX stock results show that Protalix BioTherapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Performance YTD -40.11% -40.11% 1 Month -4.39% -4.39% 3 Month -3.54% -3.54% 6 Month -25.85% -25.85% 1 Year -39.11% -39.11% More News Read More 12 Health Care Stocks Moving In Friday's Pre-Market Session May 10, 2024 Via Benzinga Pullix Gains Momentum As Gamestop Exits NFT Space January 14, 2024 Via Talk Markets Protalix BioTherapeutics And 2 Other Penny Stocks Insiders Are Buying October 23, 2023 Via Benzinga Topics Stocks Exposures US Equities Preview: Protalix BioTherapeutics's Earnings August 04, 2023 Via Benzinga Protalix Clocks 40% Decline In Q1 Revenues Reflecting Lower Sales To Brazil May 04, 2023 Via Benzinga Earnings Preview For Protalix BioTherapeutics February 24, 2023 Via Benzinga Earnings Scheduled For March 14, 2024 March 14, 2024 Via Benzinga Earnings Preview: Protalix BioTherapeutics March 13, 2024 Via Benzinga Earnings Scheduled For November 6, 2023 November 06, 2023 Via Benzinga Earnings Preview For Protalix BioTherapeutics November 03, 2023 Via Benzinga Looking Into Protalix BioTherapeutics's Return On Capital Employed December 23, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session August 07, 2023 Via Benzinga Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics May 10, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 10, 2023 Via InvestorPlace Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket February 27, 2023 Via Benzinga Protalix BioTherapeutics Well Placed to Advance in 2023 December 12, 2022 Via Talk Markets Earnings Scheduled For February 27, 2023 February 27, 2023 Via Benzinga $12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying January 06, 2023 Via Benzinga Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment November 30, 2022 Via News Direct Exposures Product Safety Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment November 30, 2022 Via TheNewswire.com Exposures Product Safety Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment November 29, 2022 Via Benzinga Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions September 21, 2022 Via TheNewswire.com Earnings Scheduled For November 14, 2022 November 14, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
